Author: Najja Parker / Source: WPXI
Yet another blood pressure medication has been added to the list of recalled hypertension drugs.
Mylan Pharmaceuticals has voluntarily expanded its recall for its valsartan-containing products, the U.S. Food and Drug Administration announced.
The affected pills include valsartan, amlodipine/valsartan and valsartan/hydrochlorothiazide tablets and were distributed in the United States between March 2017 and November 2018.
The FDA has listed additional information about the specifics, including doses, lot numbers and expiration dates, on its site.According to the press release, the drugs…
The post More blood pressure medication recalled due to possible cancer risk appeared first on FeedBox.